Mohannad Al Nsour

Doctor Mohannad Al Nsour is a medical doctor and an internationally recognized expert in field epidemiology, operational research, and public health systems, and a fellow through distinction with The Faculty of Public Health at UK (FPH). Dr Al Nsour assumed several positions such as a notable researcher, advisor, and director during his career path. He also served as a consultant on several assignments with international entities.

Dr Al Nsour has been leading the Eastern Mediterranean Public Health Network (EMPHNET) since 2009, by providing strategic assistance and operational solutions, and guiding the enrichment of Field Epidemiology Training Programs (FETPs) and public health initiatives in the region. Under Dr Al Nsour’s leadership, GHD|EMPHNET emerged as a prominent collaborative platform to serve the region and support national efforts to promote public health policies, applied epidemiology, surveillance, International Health Regulations (2005) (IHR), resource mobilization, and public health programme development among others.

Dr Al Nsour is a lecturer and speaker at regional and international levels covering public health topics such as leadership, field epidemiology, delivering evidence-based recommendations, creating new opportunities, and being a catalyst for change. His areas of expertise include infectious diseases, noncommunicable diseases (NCD), and global health. 

He serves on several regional and global initiatives, association and networks as he is the Vice-chair of the Steering Committee for the Global Outbreak Alert and Response Network (GOARN), and a member in the steering committees of the Global Field Epidemiology Partnership (GFEP) and the Roadmap on Public Health and Emergency Workforce (WHO), the FETP Enterprise’s Strategic Leadership Group (SLG), the Middle East and North Africa Health Policy Forum (MENA HPF), the Lancet Commission Advisory Group and many others. He is also the founder of the International Academy of Public Health (IAPH).

Dr Al Nsour served on the Review Committee regarding amendments to the International Health Regulations (2005), the IHR Review Committee regarding Standing Recommendations for mpox, and the IHR Review Committee regarding Standing Recommendations for COVID-19.